Integration of whole-body [18F] FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes

Diamanti K, Visvanathar R, Pereira M J, Cavalli M, Pan G, Kumar C, Skrtic S, Risérus U, Eriksson J W, Kullberg J, Komorowski J, Wadelius C & Ahlström H

 

Sci Rep 10, 8343 (2020). https://doi.org/10.1038/s41598-020-64524-0